• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up2.00% Nasdaq Up1.66%

    Alexion Pharmaceuticals, Inc. (ALXN)

    -NasdaqGS
    141.11 Up 5.75(4.25%) Feb 12, 3:59PM EST
    |After Hours : 141.14 Up 0.03 (0.02%) Feb 12, 5:04PM EST
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):1.9
    Mean Recommendation (last week):1.9
    Change:0.0

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:206.11
    Median Target:213.50
    High Target:230.00
    Low Target:165.00
    No. of Brokers:18

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Jan 20, 2016Credit SuisseInitiated Neutral
    Jan 8, 2016Sun Trust Rbsn HumphreyInitiated Buy
    Jan 7, 2016Sun Trust Rbsn HumphreyInitiated Buy
    Oct 2, 2015Morgan StanleyUpgradeEqual-WeightOverweight
    Sep 14, 2015BarclaysDowngradeOverweightEqual Weight
    Sep 1, 2015Raymond JamesInitiated Strong Buy
    May 7, 2015NomuraUpgradeNeutralBuy
    Mar 26, 2012Canaccord GenuityInitiated Buy
    Feb 23, 2012UBSUpgradeNeutralBuy
    Feb 10, 2012Robert W. BairdUpgradeNeutralOutperform

    More Upgrades & Downgrades for ALXN

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy7889
    Buy6556
    Hold5444
    Underperform0000
    Sell0000

    Data provided by Thomson/First Call


    Currency in USD.